Dr. Reddy's in News
Forbes India
19th June 2013
GV Prasad: You can never have a company totally dependent on one person
W hen I came back to india after graduation in the us, I knew I wanted to start a business but what that would be I didn’t know.
Click Here for the Complete Story [PDF Format]
Business Standard
5th April 2013
A natural choice for Dr Reddy’s
G V Prasad’s elevation this week as the chairman of Dr Reddy’s Laboratories has not come as a surprise to those in the industry.
Click Here for the Complete Story [PDF Format]
The Economic Times
17th March 2013
Man who introduced India to drug called innovation
Dr Kallam Anji Reddy, founder of Hyderabad-based drugmaker Dr Reddy's Laboratories (DRL) and pioneering pharma entrepreneur who passed away on March 15, loved a challenge.
Click Here for the Complete Story [PDF Format]
The Hindu - Business Line
17th March 2013
Pharma’s free radical
Anji Reddy's commitment to research and affordable medicine was extraordinary.
Click Here for the Complete Story [PDF Format]
Entrepreneur India
1st Septmeber, 2012
Grab the opportunity when it comes
It is time for beneficiaries of liberalization to lead
Click Here for the Complete Story[PDF Format]
Business Standard
9th August, 2012
Dr. Reddy's prescription to stay ahead of the generic pack
The company has differentiated itself by focusing on internal processes and staying away from costly acquisitions. Now, it has other plans to fend off the competition.
Click Here for the Complete Story[PDF Format]
Outlook Business
4th August, 2012
A new prescription
Tectonic changes in the US generic drugs market is causing huge shifts in Indian pharma’s strategies as well.
Click Here for the Complete Story[PDF Format]
Hindu Business Line
13th July, 2012
Influence is a leadership tool
Leaders can garner respect from others and achieve set targets by effectively influencing colleagues (by Saumen Chakraborty - President and Global Chief of Quality, HR& IT at Dr. Reddy’s Laboratories Ltd).
Click Here for the Complete Story[PDF Format]
The Times Of India
30th June, 2012
Affordable innovative drugs still our priority
For Satish Reddy, joining Dr Reddy's Labs (DRL) was not a planned move, and certainly not for which he was being groomed formally.
Click Here for the Complete Story[PDF Format]
The Economic Times
14th May, 2012
Dr. Reddy’s chalks out plan to improve India performance
India's second largest pharmaceutical company, dr. Reddy's Laboratories, is on the verge of giving final touches to a comprehensive strategy to boost the much needed growth in the Indian market
Click Here for the Complete Story[PDF Format]
Business Today
13th May, 2012
Leaderspeak – GV Prasad
Click Here for the Complete Story[PDF Format]
DNA Money
12th May 2012
Dr. Reddy’s lines up strong drug pipeline
Pharmaceuticals major Dr. Reddy’s Laboratories sees a busy year ahead as it plans to launch 15-16 products in the US market, which is likely to contribute one-third to its revenues.
Click Here for the complete Story[PDF Format]
Chicago Tribune
03rd May 2012
India’s Dr. Reddy’s gets US nod for osteoporosis drug
Indian drugmaker Dr Reddy's Laboratories has received U.S. Food and Drug Administration's approval for selling ibandronate sodium tablets used to treat osteoporosis, the regulator's website showed on Thursday.
Click Here for the complete Story[PDF Format]
SCRIP Intelligence
27th April 2012
Dr Reddy's plans multi-pronged strategy to build Russian business
Dr. Reddy's appears set for a significant scale-up in Russia, including plans for a joint venture manufacturing facility, a prescription and OTx (prescription plus switch over-the-counter) thrust and a new in-licensing pact with Novartis deepening its engagement with one of its core international markets.
Click Here for the complete Story[PDF Format]
Business Standard
20th April 2012
Dr. Reddy's to replace DLF in Sensex
The Bombay Stock Exchange (BSE) said today that pharma major Dr Reddy's Laboratories will replace DLF in the benchmark 30-share Sensex.
Click Here for the Complete Story [PDF Format]
The Hindu
18th April 2012
SMT is an empowered Multi-skilled and energetic team
Developing an internal talent pool is important for organizations as it represents significant savings in terms of costs and on boarding time.
Click Here for the Complete Story [PDF Format]
The Wall Street Journal
12th March, 2012
Dr Reddy's: May Change Hedging Policy If Dollar Rises Sharply
Dr. Reddy's Laboratories Ltd. may consider revising its hedging policy if the U.S. dollar gains sharply above the upper end of the Indian generic drug maker's expectations, its chief financial officer said.
Click Here for the Complete Story[PDF Format]
The Wall Street Journal
24th February, 2012
Career Journal: Hey Boss! Don't Assume Your Top Performers Are Happy
Can good performance be taken as a parameter to judge an employee’s happiness? Not really, says Saumen Chakraborty, president and global chief of human resources, quality and information technology at Dr. Reddy’s Laboratories Ltd.
Click Here for the Complete Story[PDF Format]
Business Today
19th February, 2012
In Good Health
Anji Reddy may be unwell. But with a succession plan in place, no one is worried about the future of the company he founded
Click Here for the Complete Story[PDF Format]
The Hindu - Business Line
24th January 2012
Stage set for easy money
We are returning to a phase of more predictability, and things have improved on the inflation front.
Click Here for the Complete Story [PDF Format]-
SCRIP Intelligence
6th January 2012
Dr. Reddy's eyes biosimilars expansion and rejigs research focus
Dr. Reddy's is in talks with potential partners to push into regulated markets in the biosimilars segment.
Click Here for the complete Story[PDF Format]
Business Today
30 October, 2011
Wrong Prescription
Providing access to quality health care should be the real concern, not the perceived impact of FDI on drug prices
Click Here for the Complete Story[PDF Format]
The Economic Times
13 October, 2011
Beyond the patent cliff
It is not just Big Pharma that has to prepare for life after the 'patent cliff': patent expiries on a slew of blockbuster drugs. Leading Indian generics companies do too. According to one estimate, the value of drugs going off-patent between 2016 and 2020 will fall 62% from the value in the preceding five-year period (2011-15). For Indian companies, this means a smaller opportunity in their main business: off-patent drug exports. They will need other drivers to grow. ET breaks down four key growth drivers that could kick in around the same time for them.
Click Here for the Complete Story[PDF Format]
Reforms 2020
October, 2011
TOP 20 ENTREPRENEURS
Interview with Saumen Chakraborty, Global Chief of HR, Dr. Reddy's, Cover Column
Click Here for the Complete Story[PDF Format]
The Human Factor
September, 2011
Unbaised Exchange
Interview with Saumen Chakraborty, Global Chief of HR, Dr. Reddy's, Cover Column
Click Here for the Complete Story[PDF Format]
People Matters
19 August, 2011
Learning Curve
Cover Story Interview: GV Prasad, Chief Executive Officer and Vice Chairman, Dr. Reddy's Laboratories
Click Here for the Complete Story[PDF Format]
Outlook Business
11 June, 2011
The Responsible way
Starting out as an employee of a state-owned Indian Drugs And Pharmaceuticals in 1969, Dr. K Anji Reddy is known today not only as the Founder Chairman of Dr. Reddy's Laboratories but also for his work as the Chairman of Naandi Foundation and Dr. Reddy’s Foundation - institutions that have done commendable social work.
Click Here for the Complete Story[PDF Format]
The Financial Express
20 May, 2011
The Drug Crusader
Driven by a distinctive generics product portfolio and its own yet-to-be-discovered medicines, Dr. K Anji Reddy shares his thoughts with The Financial Express on the Dr. Reddy's becoming one of the best innovation engines from this part of the world
Click Here for the Complete Story[PDF Format]
The Economic Times
3 May, 2011
Cure for Clean water
Naandi Community Water Services for providing purifying water in villages, interview with Dr. K Anji Reddy, Chairman, Naandi Foundation
Click Here for the Complete Story [PDF Format]
The Economic Times
3 May, 2011
A Capitalist's Guide to Social Business
A market based approach to philanthropy, with one eye firmly on the bottom line, can be an effective way for enterpreneurs to meet their social goals.
Click Here for the Complete Story [PDF Format]
The Economic Times
21 April, 2011
The Unfinished Agenda
In the 1980s, he founded what would become India's second-largest generics pharma company, In the 1990s, he pionered new drug discovery in the country. In the 2000s, he sparked a mission to provide safe drinking water to all Indian villages. Yet, far from hanging up his boots, Kallam Anji Reddy is just about getting started.
Click Here for the Complete Story [PDF Format]
Outlook - Business
5 March, 2011
Passing Down The Wisdom
Three father-son duos of vulnerable business families share lessons learnt from the liberation era.
Click Here for the Complete Story [PDF Format]
Forbes India
28 January, 2011
Dr. Reddy's Is Back: The Drug Maker's New Avatar
Dr. Reddy's Returns: Dr. Reddy's Rejuvenation After a bad fall, Dr. Reddy's Laboratories is headed for a turnaround. Audacity pushed it from its perch as one of India's top drug makers. Realism is helping it make a comeback.
Click Here for the Complete Story [PDF Format]
The Economic Times
21 September, 2010
No Indian pharma firm is tier-I: Dr. Reddy's CEO
Vice-chairman and CEO, GV Prasad, talks about the strengths and weaknesses of the domestic pharma industry, the challenges facing DRL, its $3-billion target and the government's thoughts on FDI in pharma, in a candid conversation with ET.
Click Here for the Complete Story [PDF Format]
Deccan Chronicle - Business
22 February 2010
Father, scientist, pharma czar
Dr. Reddy’s Labs, the first private enterprise that took pharma MNCs head on, will shortly celebrate its silver jubilee, Dr. Anji Reddy and his son Satish Reddy talk exclusively to Deccan Chronicle about the remarkable journey of the largest Indian pharma firm.
Click Here for the Complete Story [PDF Format]
The Hindu - Business Line
19 February 2010
Reddy Formula:
25 years of robust, healthy way of doing business.
Click Here for the Complete Story [PDF Format]
Business World
August 31, 2009
Dr. Reddy's next Lab:
Dr. K Anji Reddy, Founder Chairman, intends to provide purified drinking water to villagers across India by 2020.
Click Here for the Complete Story [PDF Format]
India Today
August 24, 2009
Jobs over Degrees:
GV Prasad, Vice Chairman and CEO, talks about what it will take to transform the youth of India and create livelihood across the spectrum
Click Here for the Complete Story [PDF Format]
Business India
May 31, 2009
Innovating business models
Guest Column by: GV Prasad, Vice-Chairman & CEO Dr. Reddy’s
Serving non-traditional markets through innovation is success too.
Click Here for the Complete Story [PDF Format]-
Financial Express
9th April, 2009
BEYOND THE BOARD
‘Entrepreneurship fuels innovation’
The first and the last word for the 41-year-old Satish Reddy is to provide affordable healthcare needs with personal commitments. Perhaps, this dictum helped the managing director and chief operating officer of NYSE-listed Dr Reddy’s Laboratories to be recognised as a Young Global Leader 2007 by the World Economic Forum.
Click Here for the Complete Story [HTML Format]
-
Financial Express
27th October, 2008
Sustainability is mandatory for business survival
Interview: GV Prasad, Vice-Chairman & CEO Dr. Reddy’s
Dr Reddy’s Laboratories is a leader in more ways than one. The company has a lesser-known distinction of being the first pharma company in India to publish a sustainability report. Last week the com-pany released its fifth annual report with the theme The Journey of Sustainability. GV Prasad, vice-chairman and chief executive officer, talks about the report and the company’s philosophy on sustainability in an email interview with the FE
Click Here for the complete Story[HTML Format] -
The Economic Times
September 29, 2008
Helping hand of a medicine man
Just what constitutes the idea of a Corporate Citizen? Is it a company's CSR (corporate social responsibility) initiatives or does it entail an ethical way of doing business... And the honour went to Dr Reddy's Foundation (DRF), the CSR arm of Dr Reddy's Labs.
Click Here for the complete Story[HTML Format] 
Business Week
March 17, 2008
Dr. Reddy's Mode of Discovery
The Indian drugmaker's CEO explains the company's move from generic offerings, and its intent on securing a spot among the world's top 25 pharma companies.
Click Here for the complete Story[HTML Format]
Bio Spectrum
March, 2008
Top 20 Life Sciences Institutes of India
Being the most cost effective and compliant contract manufacturing hub (for pharmaceuticals) in Asia, Indian CMO's are now becoming more innovative, diversified and are adopting state-of-the-art process technology and international standards to stay competitive.
Click Here for the complete Story[PDF Format]-
Business Today
March, 2008
Meet Anji Reddy, The Philanthropist
The Chairman of Dr. Reddy's Labs is morphing into one of India's most committed givers. Dr. Reddy's eponymous founder in now attacking social problems.
Click Here for the complete Story[PDF Format] -
Bio Spectrum
March, 2008
Dr. Reddy's aims to be a Biosimilar leader
DHyderabad-based, Dr. Reddy's Laboratories, the $1.2 billion Indian Pharma major, and one of the world's leading generics players, is making determined efforts to increase its portfolio of biosimilar products and become a global leader in the next decade in this space. A spacial report from the company's Hyderabad campus.
Click Here for the complete Story[PDF Format] 
Outlook - Profit
March, 2008
There are plenty of opportunities in emerging markets
Dr. Reddy's Laboratories' COO and MD Satish Reddy lays out his plans to take one of India's biggest pharmaceutical companies to the next level of growth.
Click Here for the complete Story[PDF Format]
Global Logistics & Supply Chain Strategies
February, 2008
TGeneric Drug Manufacturer's Supply Chain Ills
Triple-digit growth rates, regulatory issues and the highly competitive nature of the generic drug market posed complexity issues for this India-based pharmaceutical company. UPS Supply Chain Solutions helped Dr. Reddy's sort it all out.
Click Here for the complete Story[PDF Format]-
Business Today
January 27, 2008
Trials by Fire
Pharma entrepreneurs like Ajay Piramal and Anji Reddy are betting on drug discovery to double the industry's value to $129 billion by 2015.
Click Here for the complete Story[PDF Format]
Money Today
December 27, 2007
From Babu to Corporate Honcho
Career as Asset - Case Studies of successful career switches Prabir Jha's career focus did not waver nor did his professional plans go awry after quitting his cushy government job.
Click Here for the complete Story[PDF Format]-
Business India
December 16, 2007
Betting on biotech
Dr. Reddy's is concentrating now on biotechnology-based products and going for acquisitions to provide a base for launching them
Click Here for the complete Story[PDF Format] 
Ethical Corporation
October 2007
Targeting the poor sweetens the profits pill
Indian pharma multinational Dr Reddy’s chief executive G V Prasad says that patient needs and shareholder value go hand-in-hand.
Click Here for the complete Story[PDF Format]
PharmaTech.com
September 2, 2007
Leading the Pack - Lessons learned from the Top
Life isn't so relaxing at the top. Ranking first among Indian pharmaceutical companies, Dr. Reddy's Laboratories (Hyderabad) is in itself a model that a lot of companies in the Indian industry have either drawn inspiration from or at best imitated.
Click Here for the complete Story[HTML Format]-
Business Today
November 18, 2007
The Best Companies to work for in India
A BT-Mercer-TNS survey of India's best employers
Click Here for the complete Story[PDF Format] 
Los Angeles Times
June 9, 2007
Similarities in consumer bases help make the region a natural market.
Meet Anji Reddy, The Philanthropist
Ask for directions to Dr. Reddy's Laboratories Ltd. in this industrial city in central Mexico and locals will give you a curious look.Many are unfamiliar with the drug maker, one of India's largest pharmaceutical companies, which purchased a production facility here in late 2005 for about $59 million.
It may be the first time they've heard of an Indian company doing business in Mexico, but it won't be the last.
Click Here for the complete Story[HTML Format]
Rediff News
June 12, 2007
Dr Reddy's: From Rs 25 lakh to Rs 5,800 crore
The Patents Act signalled the arrival of good times for the pharmaceutical companies. Soon after the Act was announced, hundreds of companies started reverse engineering of western pharmaceutical products. There was a virtual explosion in the pharma space, with entrepreneurs making most of this opportunity.
Click Here for the complete Story[PDF Format]-
Outlook - Business
May 5, 2007
Globe, A Place For You and Me
Building global firms may not always be a stuff of fairy tales. Stick to a few basic principles, most often, you're there. Dr. Reddy's has a story for corporations looking for an international footprint.
GV Prasad Vice Chairman & CEO, Dr. Reddy's Laboratories
Click Here for the complete Story[PDF Format] 
Newsweek International
March 2007
Foe Turned Friend
Indian generic-drug makers once bedeviled Big Pharma; now they may be its best hope for success.
Click Here for the complete Story[HTML Format]
Modern Pharmaceuticals
February - March 2007
Leaders Speak Dr. K. Anji Reddy.
"Building a global generic business and increasing geographical expansion are key priorities for us"
Click Here for the complete Story[PDF Format]
Bloomberg Markets
January 2007
Dr. Reddy's Pfizer Fixation
Special feature on Dr. Reddy's Labs
India's maker of generic Prozac and Cipro, stung by flops and failed patent challenges, is staking its future on its founder's quest to create a homegrown blockbuster drug.
Click Here for the complete Story[PDF Format]
-
Outlook - Business
December 5, 2006
Carry on, Dr Reddy
Special feature on Dr. Reddy's Labs
The good times have started to roll for the pharma major, thanks to some big generic orders, acquisitions and research breakthroughs, but sustainability is what counts.
Click Here for the complete Story[PDF Format] 
INDIA TODAY
December, 2006
"First Person" with Dr.K.Anji Reddy, Chairman"
Click Here for the complete Story[PDF Format]-
Business World
November 20, 2006
"First Person" with Dr.K.Anji Reddy, Chairman
Indian companies and boutique western firms are forming research alliances that could challenge Big Pharma.
Click Here for the complete Story[PDF Format] -
Business World
November 13, 2006
Dr. Reddy's on a high.
Click Here for the complete Story[PDF Format] -
Business Today
November 5, 2006
The Best Companies to work for in India
A BT-Mercer-TNS survey of India's best employers
The good times have started to roll for the pharma major, thanks to some big generic orders, acquisitions and research breakthroughs, but sustainability is what counts.
Click Here for the complete Story[PDF Format] 
THE WEEK
September 24, 2006
Most awaited Drugs
Indian companies get ready to serve better and cheaper medicines for asthma to cardiocare and cancer.
Click Here for the complete Story[PDF Format]
FOCUS Reports
July, 2006
Exclusive Interviews - Dr.K.Anji Reddy, Chairman
March, 2006
Exclusive Interviews - Mr.G.V.Prasad, CEO &Vice-Chairman
Click Here for the complete Story[PDF Format]
Express Pharma
16 - 30 June, 2006
Winners Chronicle
Pharma Excellence Awards 2006
Click Here for the complete Story[PDF Format]-
Businessworld
June 19, 2006
"The Race to create India's first new drug" - Dr. Reddy's diabetes drug is entering the final phase of clinical trials. Three other Indian companies have molecules in advanced phases of testing. They aim to hit the market as early as 2009.
Click Here for the complete Story[PDF Format] -
Business Today
May 21, 2006
" Back In The Reckoning" - Some smart derisking strategies, a pick up in international markets and better prospects in the US have boosted Dr Reddy’s earning and stock, making it the hot pharma stock that it once was.
Click Here for the complete Story[PDF Format] -
Businessworld
May 15, 2006
"The $50 – billion Opportunity" -Ranbaxy and Dr. Reddy’s may have found the formula for cracking the US generics market.
Click Here for the complete Story[PDF Format] -
Businessworld
May 01, 2006
"This combination fits perfectly" - EUROPE has emerged as a lucrative hunting ground for Indian pharmaceutical companies. Last month, Dr. Reddy’s acquired betapharm, Germany’s third-largest generics company.
Click Here for the complete Story[PDF Format] 
Scrip Magazine
April, 2006
"Great minds think alike" - Observers will note clear parellels between Malvinder Singh and Satish Reddy's young business lives - both US-educated, the men have quickly risen to the top of two Indian pharma giants.
Click Here for the complete Story[PDF Format]-
India Today
April 03, 2006
"Prescription for Success" - With the Rs 2,500 crore takeover of a top German pharma firm, Dr Reddy’s Laboratories not only ensures a strategic global presence, but also enters the top-three league on home ground.
Click Here for the complete Story[PDF Format] -
Businessworld
April 03, 2006
"Compound Cure" - The world's first polypill, a multiple product pill for heart ailments, has been developed by Dr.Reddy's.
Click Here for the complete Story[PDF Format] -
Businessworld
March 20, 2006
"Europe Ahoy!" - Dr. Reddy’s Laboratories acquires betapharm, Germany’s fourth-largest generic company, for $570 million, in one of the biggest overseas acquisitions by an Indian company.
Click Here for the complete Story[PDF Format] 
International Herald Tribune
February 16, 2006
"Dr. Reddy's is expanding into Europe" - The Indian drug maker Dr. Reddy's Laboratories said Thursday that it would buy Betapharm Arzneimittel for E480 million to expand in Germany, Europe's biggest pharmaceutical market.
Click Here for the complete Story[HTML Format]
Management Scope
February, 2006
"Family companies form the back bone of the Indian economy." - This is true for the pharma industry too. At medicine maker Dr. Reddy's - the father, son and son-in-law sit at the governing board table. Their most formidable challenge being Alliances with Western companies. (article in Dutch)
Click Here for the complete Story[PDF Format]
BusinessWeek.com
February 08, 2006
"Generics Make a Name for Themselves" - In an otherwise lackluster pharma market, stocks like Dr. Reddy's Labs are surging. With a slather of patents set to expire, their prospects look good.
Click Here for the complete Story[HTML Format]
Chemical & Engineering News
January 30, 2006
"Dr.Reddy's gambit" - Frequent drug industry nemesis seeks to boost its custom manufacturing business.
Click Here for the complete Story[PDF Format]
-
Business Today
December 04, 2005
The Long-Term Rx - If indian pharma's frontline leaders are not looking good, consider it as a short-term bottomline blip. With smart partnerships, b product pipelines and a tight control on costs, the future is definitely not break.Click Here for the complete Story[PDF Format]
-
BusinessWeek.com
November 30, 2005
The Other Disease Plaguing Asia - Avian flu may get the headlines, but the health risks from diabetes are more severe. Help may come from India's and China's pharmasClick Here for the complete Story[PDF Format]
-
Business Today
October 23, 2005
Drugs that talk - Dr. Reddy's Labs signs another innovative deal, this time for discovery and developmentClick Here for the complete Story[PDF Format]
-
Business India
October 10 - 23, 2005
Pillar to success - This year Dr Reddy's Laboratories completes five years of its Chinese Joint venture operations, Kunsham Rotam Reddy Pharmaceutical Co Limited (KRRP).Click Here for the complete Story[PDF Format]
-
CNN.com
September 07, 2005
Imitate gives way to "innovate" - India's pharmaceutical industry increasingly turning to research - A CNN ReportClick Here for the complete Story[PDF Format] -
Business Today
August 28, 2005
Riding Out Of: Things are looking up at Dr Reddy's Labs. First quarter profits are up and the stock has gained some of the lost ground . Finally, the worst may be behind the pharma major.Click Here for the complete Story[PDF Format]
-
India Today
August 22, 2005
Search Engines: "India has an opportunity in R&D if we think out of the box. In each problem, there is an opportunity."
Kallam Anji Reddy, Chairman, DRLClick Here for the complete Story[PDF Format]
-
Business Today
July 31, 2005
Portal of Hope: In the six years since it was set up, Dr. Reddy's Foundations' Livelihood Advancement Business School has helped prepare some 35,000 underpriviledged youngsters for entry-level jobs.Click Here for the complete Story[PDF Format]
-
Business Today
India Inc: Going Global
Collector's Edition Volume II
March , 2005
India Inc: Going Global - CEOs from leading Indian companies shares their views.
GV Prasad, Executive Vice Chairman and CEO, Dr. Reddy’s Laboratories, shares his thoughts on the company's 'Globalisation Journey'.Click Here for the complete Story[PDF Format]
-
Business Today
December 04, 2005
The Long-Term Rx - If indian pharma's frontline leaders are not looking good, consider it as a short-term bottomline blip. With smart partnerships, b product pipelines and a tight control on costs, the future is definitely not break.Click Here for the complete Story[PDF Format]
-
Business Today
November 21, 2004
The best companies to work for in India
Dr. Reddy's is rated number seven across all sectors and the only pharmaceutical company to make the grade …Click Here for the complete Story[PDF Format]
-
Business World
November 8, 2004
India's most respected companies
Dr. Reddy's is rated number six across all sectors and number one in the pharmaceutical sector …Click Here for the complete Story[PDF Format]
-
www.businessworldindia.com
November 8, 2004
An interview with Dr. Uday Saxena, chief scientific officer, Dr. Reddy’s.Click Here for the complete Story[HTML Format]
-
CFO Asia
India's generic-drug companies make an audacious bid for global recognition.Click Here for the complete Story[HTML Format]
-
Business World
August 16, 2004
A Point to Prove
Dr. Reddy's is sticking to its innovation-led strategy …Click Here for the complete Story[PDF Format]
-
Business Today
India Inc : Going Global, Collector's Edition Volume I
May, 2004
The Indian MNCs
While Dr. Reddy's wants to boost its generics and bulk drugs business, its long-term focus is on developing new drugs of its own.Click Here for the complete Story[PDF Format]
-
Business Today
February 15, 2004
India’s Journey to Becoming A Developed Nation Dr. Anji Reddy's recipe to make India a developed economy.Click Here for the complete Story[PDF Format]
-
Business World
August 27, 2003
Free to Experiment
Its all about giving every employee the space to do his own thing.Click Here for the complete Story[PDF Format]
-
Industry2
August, 2003.
A well-researched approached
It was only a year ago that Dr. Reddy's (DRL) was selected by Forbes Global in its "Best under a Billion, Forbes Global Best Small companies for 2002". It was the second consecutive year for the company....Click Here for the complete Story[PDF Format]
-
Business Today
Collector's Edition Volume IV, 2003.
The New Paradigm Shift
Innovation & Globalisation
Mr GV Prasad, CEO, Dr. Reddy's elaborates on how innovation & entrepreneurship have driven the globalisation efforts of the company.Click Here for the complete Story[PDF Format]
-
Indian Management
July, 2003.
Bringing Innovation to Social Goals
The Dr. Reddy's Foundation for Human and Social Development brings innovation and entrepreneurship to the business of focussing on children and youth at risk among the urban poor.Click Here for the complete Story[PDF Format]
-
Business Today
June 22, 2003
India's Best Managed Companies
Timely manoeuvres have made it the most innovative company in the industry. And its bid to be a billion-dollar pharma major in another five years depends on that streak of good management continuing.Click Here for the complete Story[PDF Format]
-
Far Eastern EconomicReview
Apr 24, 2003.
INNOVATION: Indian Drug Companies Crack The U.S. Market
India's patent-busting drug firms are grabbing a piece of the lucrative U.S. medicine market with their affordable copies of costly drugs. How? By waging court battles with pharmaceutical giants.Click Here for the complete Story[PDF Format]
-
Businessworld
Mar 17, 2003.
Origin Of A Species
Aurigene is one of its kind. It shows how to get global talent to work in India.Click Here for the complete Story[PDF Format]
-
International Herald Tribune
Feb11, 2003.
Dr. Reddy looks to next level
Not content to copy others, firm seeks to develop its own drugs.Click Here for the complete Story[PDF Format]
-
Business World
January , 2003
Dr. Reddy's features as the 7th most respected company.Click Here for the complete Story[PDF Format]
-
Outlook Money
October , 2002
The Value Creator Award for consistently growing shareholder value.Click Here for the complete Story[PDF Format] -
Business World
October , 2002
India's pharma leaders discuss how we can be in the global big league.Click Here for the complete Story[PDF Format] -
Far Eastern Economic Review
September 2002
Far Eastern Economic Review, a leading business magazine in Asia and part of the Dow Jones Group, in conversation with Mr GV Prasad, CEO, Dr. Reddy's on the challenges facing the Company as it continues on its path to globalization.Click Here for the complete Story[HTML Format] -
Business Today
September , 2002
For long entrepreneur-driven, Dr. Reddy's lab is now focussing on building an organisation with leaders at every level. The idea: become a marketing and research powerhouse.Click Here for the complete Story[PDF Format] -
Financial Times
June 6, 2002
Drugs innovation is just what the Doctor ordered
"Innovation is where long-term value lies." says Mr. Prasad.Click Here for the complete Story[PDF Format] -
Scrip Magazine
May, 2002
Dr Anji Reddy put the Indian Pharma not just on the map but onto the New York Stock Exchange.Click Here for the complete Story[PDF Format]
-
Business India
December, 2001
Dr. Anji Reddy has demonstrated that a highly focussed small pharma company can also play in the big league of drug discoverers.Click Here for the complete Story[PDF Format] -
Forbes Global
December 2001
Pill factory to the world:
India's drug industry is growing beyond cheap knockoffs of Western innovation.Click Here for the complete Story[PDF Format] -
Business Today
July, 2001
The Molecule Millionaires - By focussing on drug research, a clutch of avant-garde drug companies is trying to create a new global niche for itself.Click Here for the complete Story[PDF Format]
